Immunogenicity of a bivalent Omicron BA.1 COVID-19 booster vaccination in people with HIV in the Netherlands

被引：0
|
作者：
Jongkees, M. J. [1 ,2 ]
Tan, N. H. [3 ]
Geers, D. [4 ]
de Vries, R. D. [4 ]
GeurtsvanKessel, C. H. [4 ]
Hensley, K. S. [1 ,2 ]
Sablerolles, S. G. [3 ]
Bogers, S. [4 ]
Blakaj, B. [5 ]
Afonso, P. Miranda [6 ]
Hansen, B. E. [6 ,7 ,8 ,9 ]
Rijnders, B. J. A. [1 ,2 ]
Brinkman, K. [10 ]
van der Kuy, H. M. [3 ]
Roukens, A. H. E. [11 ]
Rokx, C. [1 ,2 ]
机构：
[1] Erasmus MC, Sect Infect Dis, Dept Internal Med, Rotterdam, Netherlands
[2] Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands
[3] Erasmus MC, Dept Hosp Pharm, Rotterdam, Netherlands
[4] Erasmus MC, Dept Virosci, Rotterdam, Netherlands
[5] Erasmus MC, Dept Med Oncol, Rotterdam, Netherlands
[6] Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands
[7] Univ Toronto, IHPME, Toronto, ON, Canada
[8] Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada
[9] Univ Hlth Network, TGHRI, Toronto, ON, Canada
[10] OLVG Hosp, Dept Internal Med & Infect Dis, Amsterdam, Netherlands
[11] Leiden Univ, Dept Infect Dis, Med Ctr, Rotterdam, Netherlands
来源：
HIV MEDICINE | 2023年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
EACS2023:
引用
收藏
页码：305 / 306
页数：2
相关论文
共 50 条
  • [31] Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5
    Kawasuji, Hitoshi
    Morinaga, Yoshitomo
    Tani, Hideki
    Saga, Yumiko
    Yamada, Hiroshi
    Yoshida, Yoshihiro
    Takegoshi, Yusuke
    Kaneda, Makito
    Murai, Yushi
    Kimoto, Kou
    Ueno, Akitoshi
    Miyajima, Yuki
    Nagaoka, Kentaro
    Ono, Chikako
    Matsuura, Yoshiharu
    Niimi, Hideki
    Yamamoto, Yoshihiro
    MICROBIOLOGY SPECTRUM, 2023, 11 (02):
  • [32] Durability of Immune Response After COVID-19 Booster Vaccination and Association With COVID-19 Omicron Infection
    Gilboa, Mayan
    Regev-Yochay, Gili
    Mandelboim, Michal
    Indenbaum, Victoria
    Asraf, Keren
    Fluss, Ronen
    Amit, Sharon
    Mendelson, Ella
    Doolman, Ram
    Afek, Arnon
    Freedman, Laurence S.
    Kreiss, Yitshak
    Lustig, Yaniv
    JAMA NETWORK OPEN, 2022, 5 (09) : E2231778
  • [33] Is a booster dose of COVID-19 vaccines effective on newly dominant omicron subvariants among university students? Comparison between BA.1 and BA.2 dominancy
    Miyauchi, Shunsuke
    Hiyama, Toru
    Nakano, Yukiko
    Yoshino, Atsuo
    Miyake, Yoshie
    Okamoto, Yuri
    AMERICAN JOURNAL OF INFECTION CONTROL, 2023, 51 (08) : 907 - 911
  • [34] Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia
    Roberts, Thomas
    Uwenedi, Grace
    Bruton, Rachel
    Mcilroy, Graham
    Damery, Sarah
    Sylla, Panagiota
    Logan, Nicola
    Scott, Sam
    Lau, May
    Elzaidi, Ahmed
    Plass, Siobhan
    Mallick, Soumyajit
    Spencer, Katie
    Stephens, Christine
    Bentley, Christopher
    Pratt, Guy
    Zuo, Jianmin
    Paneesha, Shankara
    Willett, Brian
    Moss, Paul
    Parry, Helen
    BLOOD CANCER JOURNAL, 2024, 14 (01)
  • [35] Enhancement of Omicron-specific immune responses following bivalent COVID-19 booster vaccination in patients with chronic lymphocytic leukaemia
    Thomas Roberts
    Grace Uwenedi
    Rachel Bruton
    Graham McIlroy
    Sarah Damery
    Panagiota Sylla
    Nicola Logan
    Sam Scott
    May Lau
    Ahmed Elzaidi
    Siobhan Plass
    Soumyajit Mallick
    Katie Spencer
    Christine Stephens
    Christopher Bentley
    Guy Pratt
    Jianmin Zuo
    Shankara Paneesha
    Brian Willett
    Paul Moss
    Helen Parry
    Blood Cancer Journal, 14
  • [36] Bivalent BNT162b2 mRNA original/omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared with the monovalent COVID-19 booster
    Wagenhauser, Isabell
    Reusch, Julia
    Gabel, Alexander
    Krone, Lukas B.
    Kurzai, Oliver
    Petri, Nils
    Krone, Manuel
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (04) : 554 - 556
  • [37] Immunogenicity and Safety of Heterologous Omicron BA.1 and Bivalent SARS-CoV-2 Recombinant Spike Protein Booster Vaccines: A Phase 3 Randomized Clinical Trial
    Bennett, Chijioke
    Rivers, E. Joy
    Woo, Wayne
    Bloch, Mark
    Cheung, King
    Griffin, Paul
    Mohan, Rahul
    Deshmukh, Sachin
    Arya, Mark
    Cumming, Oscar
    Neville, A. Munro
    Pardey, Toni McCallum
    Plested, Joyce S.
    Cloney-Clark, Shane
    Zhu, Mingzhu
    Kalkeri, Raj
    Patel, Nita
    Buchanan, Agi
    Marcheschi, Alex
    Swan, Jennifer
    Smith, Gale
    Cho, Iksung
    Glenn, Gregory M.
    Walker, Robert
    Mallory, Raburn M.
    JOURNAL OF INFECTIOUS DISEASES, 2023, 230 (01): : e4 - e16
  • [38] Magnitude and Duration of Serum Neutralizing Antibody Titers Induced by a Third mRNA COVID-19 Vaccination against Omicron BA.1 in Older Individuals
    Park, Jun-Sun
    Jeon, Jaehyun
    Um, Jihye
    Choi, Youn Young
    Kim, Min-Kyung
    Lee, Kyung-Shin
    Sung, Ho Kyung
    Jang, Hee-Chang
    Chin, Bumsik
    Kim, Choon Kwan
    Oh, Myung-don
    Lee, Chang-Seop
    INFECTION AND CHEMOTHERAPY, 2024, 56 (01): : 25 - 36
  • [39] Covid-19 vaccine immunogenicity in people living with HIV-1
    Nault, Lauriane
    Marchitto, Lorie
    Goyette, Guillaume
    Tremblay-Sher, Daniel
    Fortin, Claude
    Martel-Laferriere, Valerie
    Trottier, Benoit
    Richard, Jonathan
    Durand, Madeleine
    Kaufmann, Daniel
    Finzi, Andres
    Tremblay, Cecile
    VACCINE, 2022, 40 (26) : 3633 - 3637
  • [40] COVID-19 vaccination in people living with HIV
    Perry, Melissa
    Crossan, Lisa
    Devine, Lynn
    Page, Caoimhe
    White, John
    HIV MEDICINE, 2021, 22 : 104 - 105
12345